BMC Cancer 2001, 1:19 http://www.biomedcentral.com/1471-2407/1/19 etoposide-mediated cytotoxicity of human prostate carcino- ma cell lines. Cancer Res 1995, 55:4633-4639 20. Siegall CB, Nordan RP, Fitzgerald DJ, Pastan I: Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseu- domonas exotoxin (IL6-PE40) on tumor cells. Mol. Cell. Biol 1990, 10:2443-2447 21. Chen T, Wang LH, Farrar WL: Interleukin 6 activates androgen receptor-mediated gene expression through a signal trans- ducer and activator of transcription 3-dependent pathway in LNCaP prostate cencer cells. Cancer Res 2000, 60:2132-2135 22. Siegsmund MJ, Yamazaki H, Pastan I: Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyper- plasia. J. Urol 1994, 151:1396-1399 23. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB: De- velopment and characterization of nontumorigenic and tu- morigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 1994, 54:4313-3421 24. Danielpour D: Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a lumnal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transform- ing growth factor-beta. J. Cell Science 1998, 112:169-179 25. Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D: The role of transforming growth factor-β1, -β2, -β3 in androgen- responsive growth of NRP-152 rat prostatic epithelial cells. J. Cell. Physiol 1998, 175:184-192 26. Hayward SW, Haughney PC, Lopes ES, Danielpour D, Cunha GR: The rat prostatic epithelial line NRP-152 can differentiate in vivo in response to its stromal environment. Prostate 1999, 39:205-212 27. Xu W, Angelis K, Danielpour D, Haddad MM, Bischof O, Campis J, Stavnezer E, Medrano EE: Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type β transforming growth factor. Proc. Natl. Acad. Sci. USA 2000, 97:5924-5929 28. Barton BE, Murphy TF: Constitutive expression of IL-6-like cy- tokines in normal bone marrow: Implications for myeloma pathophysiology. Cytokine 2000, 12:18-27 29. Ni Z, Lou W, Leman ES, Gao AC: Inhibition of constitutively ac- tivated Stat3 signaling pathway suppresses growth of pros- tate cancer cells. Cancer Res 2000, 60: 30. Bromberg J, JE DJ: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19:2468- 2473 31. Sano S, Kira M, Takagi S, Yoshikawa K, Takeda J, Itami S: Two dis- tinct signaling pathways in hair cycle induction: Stat3-de- pendent and – independent pathways. Proc. Natl. Acad. Sci. USA 2000, 97:13824-13829 32. Murakami-Mori K, Mori S, Taga T, Kishimoto T, Nakamura S: En- hancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding actibvity in dexamethasone- treated AIDS-associated Kaposi's sarcoma cells. J. Immunol 1997, 158:5518-5526 33. Foster CB, Lehmecher T, Samuels S, Stein S, F M, Metcalf JA, Wyvil K, Steinberg SA, Kovacs J, Blauvelt A, Yarchoan R, Chanock SJ: An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000, 96:2562-2567 34. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitski A, Kraker A, Krolewski JJ, Medvecsky P, Jove R: Activation of Stat3 in v-Src- transformed fibroblasts requires cooperation of Jak1 kinase activity. J. Biol. Chem 2000, 275:24935-24944 35. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Al- banese C, Darnell JE Jr: Stat3 as an oncogene. Cell 1999, 98:295- 293 36. Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC: Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway. Prostate 2000, 42:239-242 37. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K: Specific in- hibition of STAT3 signal transduction by PIAS3. Science 1997, 278:1803-1805 38. Spiotto MT, Chung TDK: STAT3 mediates IL-6-induced neu- roendocrine differentiation in prostate cancer cells. Prostate 2000, 42:186-195 39. Aoki Y, Yarchoan R, Wyvill K, Okamoto S-i, Little RF, Tosato G: De- tection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-liked disorders. Blood 2001, 97:2173-2176 40. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G: In- volvement of interleukin-10 (IL-10) and viral IL-6 in the spon- taneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 1999, 94:2871- 2879 41. Parravicini C, Lauri E, Baldini L, Neri A, Poli F, Sirchia G, Moroni M, Galli M, Corbellino M: Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997, 278:1969-1973 42. Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM, Fan S: Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 2001, 488:179-184 Publish with BioMed Central and every scientist can read your work free of charge "BioMedcentral will be the most significant development for disseminating the results of biomedical research in our lifetime." Paul Nurse, Director-General, Imperial Cancer Research Fund Publish with BMC and your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours - you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/manuscript/ BioMedcentral.com editorial@biomedcentral.com